FRANK PACHOLEC Insider Trading $SCL STEPAN CO
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for FRANK PACHOLEC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FRANK PACHOLEC. FRANK PACHOLEC is Vice President of R&D in STEPAN CO ($SCL) and Vice President R&D in STEPAN CO ($SCL) and Vice President, R&D in STEPAN CO ($SCL) and Vice President, Strategy in STEPAN CO ($SCL) and VP of Research & Development in STEPAN CO ($SCL) and VP Research & Development in STEPAN CO ($SCL).
FRANK PACHOLEC in STEPAN CO
Trading Symbol: SCLIndustry: SOAP, DETERGENT, CLEANING PREPARATIONS, PERFUMES, COSMETICS [2840]
Position of FRANK PACHOLEC: Vice President, Strategy, Vice President R&D, Vice President of R&D, VP of Research & Development, Vice President, R&D, VP Research & Development
Holdings: 34,904 shares
Current Value: $2,678,533
Latest Transaction: Dec 17 2019
$SCL Market Capitalization: $1.70B
$SCL Previous Close: $76.74
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of FRANK PACHOLEC in STEPAN CO
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 03 2014 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | M | 18.46 | 1,000 | 18,460 | 5,000 | |
Apr 03 2014 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 65.21 | 1,000 | 65,210 | 56,392 | 57.4 K to 56.4 K (-1.74 %) |
Apr 03 2014 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | M | 18.46 | 1,000 | 18,460 | 57,392 | 56.4 K to 57.4 K (+1.77 %) |
Mar 17 2014 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Grant | A | 62.24 | 85 | 5,290 | 56,392 | 56.3 K to 56.4 K (+0.15 %) |
Mar 10 2014 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | M | 18.46 | 1,400 | 25,844 | 6,000 | |
Mar 10 2014 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 62.21 | 1,400 | 87,094 | 56,307 | 57.7 K to 56.3 K (-2.43 %) |
Mar 10 2014 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | M | 18.46 | 1,400 | 25,844 | 57,707 | 56.3 K to 57.7 K (+2.49 %) |
Mar 06 2014 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | M | 18.46 | 2,000 | 36,920 | 7,400 | |
Mar 06 2014 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 60.71 | 2,000 | 121,420 | 56,307 | 58.3 K to 56.3 K (-3.43 %) |
Mar 06 2014 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | M | 18.46 | 2,000 | 36,920 | 58,307 | 56.3 K to 58.3 K (+3.55 %) |
Feb 20 2014 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | A | 0.00 | 1,131 | 0 | 1,131 | |
Feb 20 2014 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | A | 61.91 | 1,101 | 68,163 | 1,101 | |
Feb 20 2014 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | A | 61.91 | 3,303 | 204,489 | 3,303 | |
Dec 17 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Grant | A | 63.39 | 83 | 5,261 | 56,307 | 56.2 K to 56.3 K (+0.15 %) |
Nov 22 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | M | 16.09 | 2,000 | 32,170 | 0 | |
Nov 22 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 59.95 | 2,000 | 119,900 | 56,223 | 58.2 K to 56.2 K (-3.44 %) |
Nov 22 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | M | 16.09 | 2,000 | 32,170 | 58,223 | 56.2 K to 58.2 K (+3.56 %) |
Nov 12 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | M | 16.09 | 2,000 | 32,170 | 2,000 | |
Nov 12 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 58.55 | 2,000 | 117,100 | 56,223 | 58.2 K to 56.2 K (-3.44 %) |
Nov 12 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | M | 16.09 | 2,000 | 32,170 | 58,223 | 56.2 K to 58.2 K (+3.56 %) |
Sep 17 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Grant | A | 56.09 | 88 | 4,936 | 56,223 | 56.1 K to 56.2 K (+0.16 %) |
Jun 17 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Grant | A | 54.45 | 91 | 4,955 | 56,135 | 56 K to 56.1 K (+0.16 %) |
Mar 19 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Grant | A | 64.32 | 77 | 4,953 | 56,044 | 56 K to 56 K (+0.14 %) |
Mar 04 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | M | 0.00 | 2,344 | 0 | 0 | |
Mar 04 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | M | 0.00 | 1,969 | 0 | 55,967 | 54 K to 56 K (+3.65 %) |
Mar 04 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | P | 32.20 | 80 | 2,576 | 53,998 | 53.9 K to 54 K (+0.15 %) |
Mar 04 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | P | 29.95 | 83 | 2,486 | 53,839 | 53.8 K to 53.8 K (+0.15 %) |
Mar 04 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | P | 31.45 | 78 | 2,453 | 53,673 | 53.6 K to 53.7 K (+0.15 %) |
Mar 04 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | P | 26.78 | 91 | 2,437 | 53,516 | 53.4 K to 53.5 K (+0.17 %) |
Mar 04 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | P | 30.63 | 5 | 153 | 53,333 | 53.3 K to 53.3 K (+0.01 %) |
Mar 04 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | P | 32.00 | 5 | 160 | 53,323 | 53.3 K to 53.3 K (+0.01 %) |
Mar 04 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | P | 26.49 | 6 | 159 | 53,313 | 53.3 K to 53.3 K (+0.01 %) |
Mar 04 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | P | 26.99 | 600 | 16,194 | 53,302 | 52.7 K to 53.3 K (+1.14 %) |
Mar 04 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | P | 27.00 | 400 | 10,800 | 52,102 | 51.7 K to 52.1 K (+0.77 %) |
Mar 04 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | P | 26.19 | 6 | 157 | 51,302 | 51.3 K to 51.3 K (+0.01 %) |
Mar 04 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | P | 25.99 | 6 | 156 | 51,290 | 51.3 K to 51.3 K (+0.01 %) |
Mar 04 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | P | 21.66 | 7 | 152 | 51,279 | 51.3 K to 51.3 K (+0.01 %) |
Feb 21 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | A | 0.00 | 1,386 | 0 | 1,386 | |
Feb 21 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | A | 63.11 | 1,133 | 71,504 | 1,133 | |
Feb 21 2013 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | A | 63.11 | 2,643 | 166,800 | 2,643 | |
Dec 26 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | C | 0.00 | 12 | 0 | 0 | |
Dec 26 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | C | 0.00 | 28 | 0 | 1,368 | 1.3 K to 1.4 K (+2.09 %) |
Dec 18 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Grant | A | 100.84 | 46 | 4,639 | 52,833 | 52.8 K to 52.8 K (+0.09 %) |
Nov 27 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | M | 32.17 | 1,500 | 48,255 | 2,000 | |
Nov 27 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 98.70 | 100 | 9,870 | 26,371 | 26.5 K to 26.4 K (-0.38 %) |
Nov 27 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 97.88 | 1,400 | 137,032 | 26,471 | 27.9 K to 26.5 K (-5.02 %) |
Nov 27 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | M | 32.17 | 1,500 | 48,255 | 27,871 | 26.4 K to 27.9 K (+5.69 %) |
Nov 26 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | M | 31.70 | 1,000 | 31,700 | 0 | |
Nov 26 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | M | 31.70 | 1,500 | 47,550 | 1,000 | |
Nov 26 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 98.19 | 5 | 491 | 26,371 | 26.4 K to 26.4 K (-0.02 %) |
Nov 26 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 98.13 | 100 | 9,813 | 26,376 | 26.5 K to 26.4 K (-0.38 %) |
Nov 26 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 98.07 | 95 | 9,317 | 26,476 | 26.6 K to 26.5 K (-0.36 %) |
Nov 26 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 98.03 | 100 | 9,803 | 26,571 | 26.7 K to 26.6 K (-0.37 %) |
Nov 26 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 97.91 | 100 | 9,791 | 26,671 | 26.8 K to 26.7 K (-0.37 %) |
Nov 26 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 97.88 | 100 | 9,788 | 26,771 | 26.9 K to 26.8 K (-0.37 %) |
Nov 26 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 97.86 | 200 | 19,572 | 26,871 | 27.1 K to 26.9 K (-0.74 %) |
Nov 26 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 97.85 | 200 | 19,570 | 27,071 | 27.3 K to 27.1 K (-0.73 %) |
Nov 26 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 97.65 | 100 | 9,765 | 27,271 | 27.4 K to 27.3 K (-0.37 %) |
Nov 26 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | M | 31.70 | 1,000 | 31,700 | 27,371 | 26.4 K to 27.4 K (+3.79 %) |
Nov 26 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 98.68 | 100 | 9,868 | 26,371 | 26.5 K to 26.4 K (-0.38 %) |
Nov 26 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 97.76 | 1,400 | 136,864 | 26,471 | 27.9 K to 26.5 K (-5.02 %) |
Nov 26 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | M | 31.70 | 1,500 | 47,550 | 27,871 | 26.4 K to 27.9 K (+5.69 %) |
Nov 21 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | M | 31.70 | 1,000 | 31,700 | 2,500 | |
Nov 21 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | M | 26.25 | 1,000 | 26,250 | 0 | |
Nov 21 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 98.58 | 100 | 9,858 | 26,371 | 26.5 K to 26.4 K (-0.38 %) |
Nov 21 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 98.53 | 202 | 19,903 | 26,471 | 26.7 K to 26.5 K (-0.76 %) |
Nov 21 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 98.52 | 208 | 20,492 | 26,673 | 26.9 K to 26.7 K (-0.77 %) |
Nov 21 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 98.51 | 200 | 19,702 | 26,881 | 27.1 K to 26.9 K (-0.74 %) |
Nov 21 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 98.49 | 100 | 9,849 | 27,081 | 27.2 K to 27.1 K (-0.37 %) |
Nov 21 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 98.48 | 100 | 9,848 | 27,181 | 27.3 K to 27.2 K (-0.37 %) |
Nov 21 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 98.34 | 4 | 393 | 27,281 | 27.3 K to 27.3 K (-0.01 %) |
Nov 21 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 98.20 | 86 | 8,445 | 27,285 | 27.4 K to 27.3 K (-0.31 %) |
Nov 21 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | M | 31.70 | 1,000 | 31,700 | 27,371 | 26.4 K to 27.4 K (+3.79 %) |
Nov 21 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 96.24 | 500 | 48,120 | 26,371 | 26.9 K to 26.4 K (-1.86 %) |
Nov 21 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 96.00 | 200 | 19,200 | 26,871 | 27.1 K to 26.9 K (-0.74 %) |
Nov 21 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 95.92 | 300 | 28,777 | 27,071 | 27.4 K to 27.1 K (-1.10 %) |
Nov 21 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | M | 26.25 | 1,000 | 26,250 | 27,371 | 26.4 K to 27.4 K (+3.79 %) |
Nov 08 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | M | 26.25 | 1,000 | 26,250 | 1,000 | |
Nov 08 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 99.00 | 350 | 34,650 | 26,371 | 26.7 K to 26.4 K (-1.31 %) |
Nov 08 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 98.96 | 324 | 32,063 | 26,721 | 27 K to 26.7 K (-1.20 %) |
Nov 08 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 98.90 | 100 | 9,890 | 27,045 | 27.1 K to 27 K (-0.37 %) |
Nov 08 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 98.88 | 112 | 11,075 | 27,145 | 27.3 K to 27.1 K (-0.41 %) |
Nov 08 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 98.20 | 100 | 9,820 | 27,257 | 27.4 K to 27.3 K (-0.37 %) |
Nov 08 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 98.14 | 14 | 1,374 | 27,357 | 27.4 K to 27.4 K (-0.05 %) |
Nov 08 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | M | 26.25 | 1,000 | 26,250 | 27,371 | 26.4 K to 27.4 K (+3.79 %) |
Sep 18 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Grant | A | 97.58 | 41 | 4,001 | 26,371 | 26.3 K to 26.4 K (+0.16 %) |
Jul 24 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | M | 26.25 | 500 | 13,125 | 2,000 | |
Jul 24 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 96.93 | 500 | 48,465 | 26,330 | 26.8 K to 26.3 K (-1.86 %) |
Jul 24 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | M | 26.25 | 500 | 13,125 | 26,830 | 26.3 K to 26.8 K (+1.90 %) |
Jul 17 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | M | 26.25 | 500 | 13,125 | 2,500 | |
Jul 17 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 94.93 | 500 | 47,465 | 26,330 | 26.8 K to 26.3 K (-1.86 %) |
Jul 17 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | M | 26.25 | 500 | 13,125 | 26,830 | 26.3 K to 26.8 K (+1.90 %) |
Jun 19 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Grant | A | 93.10 | 43 | 4,003 | 26,330 | 26.3 K to 26.3 K (+0.16 %) |
May 30 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | M | 26.25 | 500 | 13,125 | 3,000 | |
May 30 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 91.01 | 100 | 9,101 | 26,287 | 26.4 K to 26.3 K (-0.38 %) |
May 30 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 90.92 | 100 | 9,092 | 26,387 | 26.5 K to 26.4 K (-0.38 %) |
May 30 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 90.91 | 200 | 18,182 | 26,487 | 26.7 K to 26.5 K (-0.75 %) |
May 30 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 90.80 | 100 | 9,080 | 26,687 | 26.8 K to 26.7 K (-0.37 %) |
May 30 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | M | 26.25 | 500 | 13,125 | 26,787 | 26.3 K to 26.8 K (+1.90 %) |
Mar 16 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Grant | A | 86.15 | 46 | 3,963 | 26,287 | 26.2 K to 26.3 K (+0.18 %) |
Feb 29 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | M | 25.39 | 2,000 | 50,770 | 0 | |
Feb 29 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 86.52 | 2,000 | 173,046 | 26,240 | 28.2 K to 26.2 K (-7.08 %) |
Feb 29 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | M | 25.39 | 2,000 | 50,770 | 28,240 | 26.2 K to 28.2 K (+7.62 %) |
Feb 24 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | M | 0.00 | 1,250 | 0 | 0 | |
Feb 24 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Grant | A | 0.00 | 1,250 | 0 | 26,240 | 25 K to 26.2 K (+5.00 %) |
Feb 24 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | M | 0.00 | 1,250 | 0 | 24,990 | 23.7 K to 25 K (+5.27 %) |
Feb 16 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | A | 0.00 | 807 | 0 | 807 | |
Feb 16 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | A | 85.53 | 746 | 63,805 | 746 | |
Feb 16 2012 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | A | 85.53 | 746 | 63,805 | 746 | |
Dec 16 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Grant | A | 77.99 | 42 | 3,276 | 23,740 | 23.7 K to 23.7 K (+0.18 %) |
Nov 22 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | M | 24.94 | 509 | 12,694 | 0 | |
Nov 22 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 77.28 | 200 | 15,456 | 23,698 | 23.9 K to 23.7 K (-0.84 %) |
Nov 22 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 77.19 | 9 | 695 | 23,898 | 23.9 K to 23.9 K (-0.04 %) |
Nov 22 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 76.82 | 300 | 23,046 | 23,907 | 24.2 K to 23.9 K (-1.24 %) |
Nov 22 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | M | 24.94 | 509 | 12,694 | 24,207 | 23.7 K to 24.2 K (+2.15 %) |
Oct 31 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | M | 25.39 | 1,000 | 25,385 | 2,000 | |
Oct 31 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 81.14 | 1,000 | 81,140 | 23,698 | 24.7 K to 23.7 K (-4.05 %) |
Oct 31 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | M | 25.39 | 1,000 | 25,385 | 24,698 | 23.7 K to 24.7 K (+4.22 %) |
Sep 19 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Grant | A | 72.19 | 42 | 3,032 | 23,698 | 23.7 K to 23.7 K (+0.18 %) |
Aug 30 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | M | 25.39 | 939 | 23,837 | 3,000 | |
Aug 30 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 75.56 | 939 | 70,947 | 24,232 | 25.2 K to 24.2 K (-3.73 %) |
Aug 30 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | M | 25.39 | 939 | 23,837 | 25,171 | 24.2 K to 25.2 K (+3.88 %) |
Aug 08 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | M | 24.94 | 2,000 | 49,880 | 509 | |
Aug 08 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 74.88 | 800 | 59,901 | 24,232 | 25 K to 24.2 K (-3.20 %) |
Aug 08 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | M | 24.94 | 800 | 19,952 | 25,032 | 24.2 K to 25 K (+3.30 %) |
Aug 08 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 73.69 | 1,200 | 88,430 | 24,232 | 25.4 K to 24.2 K (-4.72 %) |
Aug 08 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | M | 24.94 | 1,200 | 29,928 | 25,432 | 24.2 K to 25.4 K (+4.95 %) |
Jun 16 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Grant | A | 65.78 | 46 | 3,026 | 24,232 | 24.2 K to 24.2 K (+0.19 %) |
Jun 02 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | M | 24.94 | 519 | 12,944 | 2,509 | |
Jun 02 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | M | 25.39 | 379 | 9,621 | 3,939 | |
Jun 02 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 67.02 | 335 | 22,452 | 24,186 | 24.5 K to 24.2 K (-1.37 %) |
Jun 02 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 66.90 | 184 | 12,310 | 24,521 | 24.7 K to 24.5 K (-0.74 %) |
Jun 02 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | M | 24.94 | 519 | 12,944 | 24,705 | 24.2 K to 24.7 K (+2.15 %) |
Jun 02 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 67.07 | 379 | 25,420 | 24,186 | 24.6 K to 24.2 K (-1.54 %) |
Jun 02 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | M | 25.39 | 379 | 9,621 | 24,565 | 24.2 K to 24.6 K (+1.57 %) |
May 24 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | J | 0.00 | 111 | 0 | 24,186 | 24.1 K to 24.2 K (+0.46 %) |
Mar 17 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Grant | A | 70.05 | 43 | 3,012 | 24,075 | 24 K to 24.1 K (+0.18 %) |
Feb 16 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | M | 0.00 | 2,000 | 0 | 0 | |
Feb 16 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | J | 0.00 | 6 | 0 | 24,032 | 24 K to 24 K (+0.02 %) |
Feb 16 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Grant | A | 0.00 | 2,000 | 0 | 24,026 | 22 K to 24 K (+9.08 %) |
Feb 16 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | M | 0.00 | 2,000 | 0 | 22,026 | 20 K to 22 K (+9.99 %) |
Feb 09 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | A | 0.00 | 880 | 0 | 880 | |
Feb 09 2011 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | A | 75.02 | 1,590 | 119,282 | 1,590 | |
Dec 17 2010 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Grant | A | 74.73 | 26 | 1,943 | 20,026 | 20 K to 20 K (+0.13 %) |
Sep 17 2010 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Grant | A | 59.25 | 31 | 1,837 | 20,000 | 20 K to 20 K (+0.16 %) |
Jun 17 2010 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Grant | A | 69.27 | 26 | 1,801 | 19,969 | 19.9 K to 20 K (+0.13 %) |
May 10 2010 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | J | 0.00 | 175 | 0 | 19,943 | 19.8 K to 19.9 K (+0.89 %) |
Apr 30 2010 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Option Exercise | M | 24.94 | 1,500 | 37,410 | 3,028 | |
Apr 30 2010 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Sell | S | 77.48 | 1,500 | 116,220 | 19,768 | 21.3 K to 19.8 K (-7.05 %) |
Apr 30 2010 | SCL | STEPAN CO | PACHOLEC FRANK | Vice President R&D | Buy | M | 24.94 | 1,500 | 37,410 | 21,268 | 19.8 K to 21.3 K (+7.59 %) |